Exercise and bone health across the lifespan by Santos, L et al.
RESEARCH ARTICLE
Exercise and bone health across the lifespan
Lı´via Santos . Kirsty Jayne Elliott-Sale . Craig Sale
Received: 28 March 2017 / Accepted: 10 October 2017
 The Author(s) 2017. This article is an open access publication
Abstract With ageing, bone tissue undergoes sig-
nificant compositional, architectural and metabolic
alterations potentially leading to osteoporosis. Osteo-
porosis is the most prevalent bone disorder, which is
characterised by progressive bone weakening and an
increased risk of fragility fractures. Although this
metabolic disease is conventionally associated with
ageing and menopause, the predisposing factors are
thought to be established during childhood and
adolescence. In light of this, exercise interventions
implemented during maturation are likely to be highly
beneficial as part of a long-term strategy to maximise
peak bone mass and hence delay the onset of age- or
menopause-related osteoporosis. This notion is sup-
ported by data on exercise interventions implemented
during childhood and adolescence, which confirmed
that weight-bearing activity, particularly if undertaken
during peripubertal development, is capable of gener-
ating a significant osteogenic response leading to bone
anabolism. Recent work on human ageing and epige-
netics suggests that undertaking exercise after the
fourth decade of life is still important, given the anti-
ageing effect and health benefits provided, potentially
occurring via a delay in telomere shortening and
modification of DNA methylation patterns associated
with ageing. Exercise is among the primary modifiable
factors capable of influencing bone health by preserv-
ing bone mass and strength, preventing the death of
bone cells and anti-ageing action provided.
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Introduction
Ageing is accompanied by the loss of bone mass and
strength, predisposing the skeleton to the onset of
osteoporosis (Demontiero et al. 2012). Osteoporosis is
a metabolic disorder prevalent in post-menopausal
women, characterised by accentuated bone weaken-
ing, greater susceptibility to fragility fractures (Hern-
lund et al. 2013), but also higher mortality risks (Klop
et al. 2017; Panula et al. 2011). Hip fractures and
associated comorbidities in particular, are responsible
for the increase in 1-year mortality risks by more than
threefold when compared with those without a bone
fracture (Klop et al. 2017; Panula et al. 2011).
Osteoporosis is estimated to affect 22 million
women and 5.5 million men in the EU (Hernlund
et al. 2013). In 2010, there were 3.5 M osteoporotoic
fractures reported in the EU; 620,000 hip fractures,
520,000 vertebral fractures, 560,000 forearm fractures
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and 1,800,000 other fractures (Hernlund et al. 2013).
In the UK, 3.21 M people, aged over 50 years, are
living with osteoporosis, with more than 536,000 new
fragility fractures occur every year (Svedbom et al.
2013). The prevalence of osteoporosis is expected to
rise over the next decades by virtue of population
ageing. One-third of the UK population is 50 years old
or above, and current estimates suggest this age
segment will grow from 21.6 million in 2010 to 26.2
million in 2025, corresponding to an increase of 21%
(UK Office for National Statistics 2016).
Osteoporosis and other musculoskletal disorders,
particularly osteoarthritis and bone trauma, are
amongst the most common problems affecting the
elderly and are a leading cause of physical disability
(Gheno et al. 2012; Weinstein 2016). Limitations in
mobility and independance are psychologically dev-
astating and represent a huge economic challenge to
the sustainability of health care systems (Gheno et al.
2012; Weinstein 2016). Exercise, nutrition and phar-
macological interventions may help the management
of age-related bone loss and osteoporosis. Certain
types of exercise might result in improved bone
strength even after menopause, a time when bone mass
declines and the ability to rescue lost bone is impaired
(Polidoulis et al. 2011; Uusi-Rasi et al. 2003). With
regard to nutrition, vitamin D is essential in calcium
metabolism and oral intake may prevent fractures in
osteoporotic patients (Lips et al. 2006). Pharmacolog-
ical interventions are the gold standard with regards to
osteoporosis management and prevention of fragility
fractures, although their benefits are transient and
might induce rare but severe side effects (Gozansky
et al. 2005; Woo et al. 2006). Some of the concerns
raised as a result of these side effects might well have
contributed to the declining prescription of these drugs
or the reduction in actual use of prescribed medica-
tions for low bone mass (Jha et al. 2015).
Exercise is one of the primary modifiable factors
associated with improved bone health outcomes, such
as high bone mineral density (BMD) and strength
(Weaver et al. 2016). Individuals who undertake
exercise on a regular basis are also more likely to
prevent age-relate bone loss and experience fewer falls
and fractures by virtue of developing stronger muscles
and bones, which improve balance (Liu-Ambrose
et al. 2004). In addition to this, exercise may provide a
‘‘rejuvenating effect’’ and, as a result, the potential to
mitigate age-related bone loss and diseases (Loprinzi
et al. 2015). In this article, we review the benefits of
undertaking exercise throughout life as part of a
strategy to promote bone health across the lifespan,
and advance some cellular and molecular mechanisms
potentially activated upon exercise that underpin such
benefits. We will also highlight some areas where the
clinical benefits of exercise on bone health might have
been slightly exaggerated, given that increases in bone
mass as a result of exercise are typically in the range of
1–10% at the most and reductions in bone mass across
the lifespan are significantly greater (Riggs et al.
2004).
Bone and muscle are the two largest tissues of the
musculoskeletal system and they are coupled mechan-
ically, biochemically and molecularly (Brotto and
Bonewald 2015), with muscular contraction thought to
be the main source of mechanical strain leading to
bone adaptation (Bakker et al. 2001; Burr 1997). Bone
and muscle mass/strength are proportionally related,
as evidenced by a study showing that under disuse
conditions, muscle mass declines followed by a loss of
bone mass, while during recovery muscle mass gains
precede bone accretion (Sieva¨nen et al. 1996).
Although coupling between the two tissues and further
interactions with other elements of the musculoskele-
tal system, particularly tendons, ligaments and carti-
lage is unquestionable, particularly in relation to the
prevention of falls (perhaps the major contributor to
bone fracture), this is beyond the scope of the present
review.
Ageing and bone loss
Ageing
Ageing is a physiological process that results from the
accumulation of molecular and cellular damage over
time (WHO 2015). It is influenced by the human
genome and epigenetic changes triggered by environ-
mental and lifestyle factors (Govindaraju et al. 2015).
Human ageing is generally accompanied by a decline
of cognitive and motor functions (Moustafa 2014) and
is considered the main risk factor for developing
musculoskeletal, neurodegenerative and cardiovascu-
lar diseases (Niccoli and Partridge 2012). Genetic
studies on progeroid syndromes, clinical conditions of
premature ageing, have been useful to understand
physiological ageing and age-related diseases (Martin
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and Junko 2010). Research on Hutchison-Gilford and
Werner progeroid syndromes, in particular, have
allowed the identification of several hallmarks of
physiological ageing, such as telomere shortening,
mitochondrial dysfunction, oxidative stress and cell
senescence (Childs et al. 2015; Lo´pez-Otı´n et al.
2013). Briefly, telomeres are protective caps located at
the end of chromosomes with the purpose of prevent-
ing deterioration or fusion with other chromosomes.
Telomere shortening exacerbates human ageing, as
well as inducing metabolic alterations, such as insulin
resistance, b-cell failure and glucose intolerance
(Gardner et al. 2005; Shimizu et al. 2014). The
mitochondria are organelles that generate the majority
of the chemical energy utilised by cells, adenosine
triphosphate (ATP). Mitochondrial dysfunction is
caused by depletion of nicotinamide adenine dinu-
cleotide (NAD?) and downregulation of the tricar-
boxylic acid and oxidative phosphorylation
(OXPHOS) pathways (Zhang et al. 2016), leading to
a decline in respiratory function and stem cell
senescence (Wiley et al. 2016; Zhang et al. 2016).
Senescent cells exhibit stress-induced permanent
proliferative arrest and are thought to drive ageing
and age-related pathologies (Baker et al. 2016; Childs
et al. 2015). While in proliferative arrest, senescent
cells secrete specific proteins, referred to as the se-
nescence-associated secretory phenotype (SASP),
which can exacerbate the proliferative arrest and also
induce senescence in a paracrine manner. Interest-
ingly, recent evidence came to light showing that the
SASP can also exert a proregenerative effect through
cell plasticity and stemness (Ritschka et al. 2017).
Lastly, excessive or persistent oxidative stress caused
by the action of free radicals, non-ionising radiation
and inflammatory agents, and from mitochondrial by-
products (e.g., peroxides), was proposed to contribute
to accumulated DNA damage and activation of
apoptotic signalling pathways, potentially accelerat-
ing ageing (Kryston et al. 2011; Lu et al. 2012).
Oxidative stress was identified as an important driver
of bone ageing. This marker will be further discussed
in the next section (Ambrogini et al. 2010; Manolagas
2010).
Age-related bone loss
Bone accretion occurs from birth and throughout
childhood and adolescence, with approximately 90%
of bone mass acquired by the age of 20 years (Henry
et al. 2004; Recker et al. 1992). Acquisition of bone
mass follows sex and age specific patterns, as
evidenced in Fig. 1. Men have greater BMD than
women and this difference becomes starker as sexual
maturation progresses (Hendrickx et al. 2015). When
women reach late 30s and men early 40s, BMD starts
to decline and this trend persists throughout life
(Fig. 1). Such decline is further accompanied by a
decrease in bone strength strength (Wall et al. 1979),
osteocyte death, deteoration of type I collagen (Bailey
and Knott 1999) and adipogenesis at the expense of
osteogenesis (Justesen et al. 2001). Age-related bone
loss occurs due to greater bone resorption than bone
formation, a process that culminates in reduced
trabecular volume and diminished cortical bone width
(McCalden et al. 1993). For a comprehensive review
of these changes see (Boskey and Coleman 2010;
Manolagas and Parfitt 2010).
Oxidative stress has been identified as a critical
driver of bone ageing (Ambrogini et al. 2010;
Manolagas 2010). Production of mitochondrial super-
oxide anion (O2
-) in aged osteocytes led to increased
osteoclast-mediated bone resorption (Kobayashi et al.
2015). In addition to this, the presence of reactive
oxygen species (ROS) has been shown to attenuate b-
catenin signalling with concomitant activation of
PPARc favouring adipogenesis at the expense of
osteoblastogenesis and bone formation (Manolagas
2010). The loss of function of oxidative defense
Forkhead box O (FOXOs), a family of genes impli-
cated in ageing and longevity, triggers the apoptosis of
osteoblasts and osteocytes and the advance of an
osteoporotic phenotype (Ambrogini et al. 2010). In
this same study, the authors showed that an overex-
pression of FOXO3 in osteoblasts culminated in
increased bone mass. These findings demonstrate that
signalling pathways implicated in bone cell survival
and osteogenesis are negatively affected by oxidative
stress leading to age-related bone loss and potentially
osteoporosis.
The osteoporotic bone
Osteoporosis is the most prevalent disease in post-
menopausal women and is accompanied by an
increased risk of fragility fractures (Ji and Yu 2015).
Fragility fractures occur primarily in the spine, hip and
Biogerontology
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wrist (NICE 2012). Hip fractures cause permanent
disability in 50% of the cases and death in 20%
(Sernbo and Johnell 1993). In the UK, 300,000
fragility fractures occur every year (British Orthopae-
dic Association 2007), with direct medical costs
estimated at £1.8 billion in 2000 and projected to
reach £2.2 billion by 2025 (Burge et al. 2001).
Osteoporosis arises from the imbalance between
bone resorption (osteoclast-mediated) and bone for-
mation (osteoblast-mediated), with bone resorption
exceeding bone formation. At histopathological level,
the osteoporotic bone is less compact as a result of
bone thining or loss, presents a strong reduction in the
trabecular connectivity and greater adiposity of the
bone marrow (Marcu et al. 2011).
Oxidative stress and oestrogen depletion are two
important mechanisms underpinning osteoporosis.
Oxidative stress was reported to direct commitment
of mesenchymal progenitors towards the adipogenic
lineage at the expense of osteoblastogenesis (Manola-
gas 2010), which can explain greater adipodicity of the
bone marrow in old and osteroporotic bone (Justesen
et al. 2001). Oestrogen has a protective role in bone
health e.g., by controlling bone resorption activity.
This was demonstrated by studies evidencing that
oestrogen inhibits osteoclast formation and activity
via increased production of osteoprotegerin (Hofbauer
et al. 1999) or transforming growth factor b (Hofbauer
et al. 1999; Hughes et al. 1996), and may also induce
apoptosis of osteoclast progenitor cells via blocking of
the cytokine receptor activator of NFjB ligand
(RANKL) (Lundberg et al. 2001). Oestrogen action
on bone resorption activity was further confirmed by a
study showing that selective deletion of the oestrogen
receptor-a (ERa) in osteoclast lineage cells increased
osteoclastogenesis activity and abrogated the oestro-
gen-mediated pro-apoptotic action in osteoclasts
(Almeida et al. 2013). These changes led to increased
bone resorption in women, but not in men, causing a
loss of cancellous, but not cortical, bone (Almeida
et al. 2013). When oestrogen is depleted in the
organism, e.g., post-menopause, this protective effect
on bone health is reduced or disappears and this
increases predisposition to the onset of bone diseases
like osteoporosis.
Osteoporosis is conventionally appraised by dual-
energy X-ray absorptiometry (DXA) and the resultant
BMD values are compared to the BMD of young
healthy individuals of the same gender, thus generat-
ing a T score. A T score of-1 and above is considered
normal, a score between -1 and -2.5 is indicative of
osteopenia, and a score of -2.5 or below signifies
osteoporosis. This categorisation was established by
the Word Health Organisation (WHO) to standardise
the diagnosis of oesteoporosis, particularly in Cau-
casian, postmenopausal women. BMD values can also
Fig. 1 Bone mass density
(BMD) across the lifespan.
Men exhibit higher BMDs
throughout life and are less
susceptible to age-related
bone loss than women.
Adapted from Hendrickx
et al. (2015)
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be compared to the BMD of age-matched individuals
with normal bone mass to generate a Z score. Z Scores
are mostly utilised in cases of severe osteoporosis.
BMD is, however, only one element of bone strength,
with areal BMD (aBMD) accounting for 65–75% of
the variance in bone strength. As such, there is a need
to also consider volumetric BMD, bone geometry and
bone architecture.
According to the severity of bone loss, the presence
of fragility fractures and other clinical factors, patients
may be prescribed with anti-osteoporotic drugs, pri-
marily the oral intake of bisphosphonates, such as
alendronate. Third generation (nitrogen-containing)
alendronate binds to bone mineral and is metabolised
by osteoclasts leading to the inhibition of bone
resorptive activities and an increase of bone strength
(Boivin et al. 2000). Another important anti-bone
resorption drug is strontium ranelate, although its
mechanism of action differs from bisphosphonates by
targeting bone formation and mineralisation directly,
rather than by suppressing osteoclast-mediated bone
resorption activity (Marie 2007). Denosumab is a
human monoclonal antibody that binds to RANKL,
inhibiting it. RANKL suppression impairs osteoclast
maturation and survival leading to the diminution of
bone resorption activity (Hanley et al. 2012). The
teriparatide human recombinant parathyroid hormone
(hrPTH), is clinically approved for the treatment of
osteoporosis due to its anabolic effect on bone and its
ability to rescue skeleton strength (Pazianas 2015).
The use of hrPTH is recommended for up to
24 months and has been shown to reduce fracture
risks (Lindsay et al. 2016; Neer et al. 2001).
The prescription of anti-osteoporotic drugs is vital
for the management of osteoporosis and its related co-
morbidities, although they are not always effective and
the benefits are transient (Gozansky et al. 2005).
Gozansky et al. (2005) investigated the efficacy of
oestrogen and raloxifene in conserving BMD during a
6-month exercise-based weight loss program (Gozan-
sky et al. 2005), where participants were allowed to
select the mode(s) of exercise e.g., treadmill, walking/
running, cycling, among others. The authors showed
that both pharmacological interventions failed to
maintain intact lumbar spine, total hip and trochanter
BMD in post-menopausal women enrolled in a lost
weight program, although BMD losses were more
pronounced in women belonging to the placebo group
(Gozansky et al. 2005). With regard to side effects,
long-term use of bisphosphonates can cause severe
collateral damage, such as jaw necrosis (Woo et al.
2006). In light of this, it has been advocated that
regular exercise might be one of the best non-
pharmacological approaches to support bone health
across the lifespan (Gomez-Cabello et al. 2012), either
by maximising peak bone mass during maturation,
delaying the onset of osteoporosis later in life (Tveit
et al. 2015; Warden et al. 2007) and/or by mitigating
the age and/or menopausal-related bone loss (Howe
et al. 2011; Polidoulis et al. 2011). Much of the
evidence in support of a positive effect of exercise on
bone is, however, observational and many of the direct
exercise intervention studies have not shown such
large effects on bone. Over the next sections the
influence of exercise on age-related bone loss and
osteoporosis will be discussed.
Bone remodelling and adaptation to exercise
Bone is a heterogeneous tissue made up of two
components, an organic part comprised of collagenous
and non-collagenous proteins and cells and a mineral
component of hydroxyapatite (Boskey 2013). Bone
contains three major cell types: osteoblasts, which
derive from mesenchymal stem cells and are respon-
sible for bone formation; osteocytes, dendritic cells
terminally differentiated from osteoblasts embedded
in the bone matrix, accounting for more than 90% of
bone cells; and osteoclasts, large multinucleated cells
differentiated from hematopoietic progenitor cells that
mediate bone resorption (Schaffler et al. 2014;
Tatsumi et al. 2007). The coordinated action of
osteoblasts, osteoclasts and osteocytes orchestrate
bone modelling and remodelling. Bone modelling
occurs to accommodate the radial and longitudinal
growth of bone during the growing years and to adapt
the skeleton to mechanical strain, whereas remod-
elling happens mainly during adulthood to remove
microdamaged and old bone, adapt bone tissue to
mechanical loading and maintain the strength and
integrity of the skeleton (Sims and Martin 2014).
During modelling, osteoclastogenesis and osteogene-
sis work independently, whereas in remodelling, bone
resorption and formation are coupled, taking place in
bone remodelling units (Baron and Kneissel 2013).
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Bone adaptation to exercise
Exercise leads to bone adaptation and this process is
mediated by cellular mechanotransduction (Goodman
et al. 2015). Briefly, upon exercise, bone tissue
deforms, and the mechanosensors located throughout
the cells, such as stretch-activated ion channels
and integrins, change their original conformation
(Guilluy et al. 2014; Ross et al. 2013). Such confor-
mational changes trigger a signalling cascade to
provide an appropriate biochemical response (Good-
man et al. 2015), e.g., osteogenesis and bone accretion
at the site of deformation.
Osteocytes are mechanotransduction hot spots due
to their unique ability to detect and respond to
mechanical strains (Klein-Nulend and Bakker 2007).
Osteocytes control bone formation and resorption
through the differentiation of osteoblasts and osteo-
clasts and by stimulating the expression of the
osteoclastogenesis inhibitor, osteoprotegerin (Regard
et al. 2012). Osteoblasts also secrete osteoprotegerin
evidencing that this cell type also presents the
potential to regulate bone resorption activity (Uda-
gawa et al. 2000).
Of critical importance is the osteocyte’s ability to
mediate the anabolic actions of the Wnt/b-catenin
signalling pathway (Tu et al. 2015). This signalling
pathway is evolutionarily conserved and can be
categorised into three forms: an inactive form, where
b-catenin is phosphorylated and degraded by ubiqui-
tination in the proteasome, and two active forms,
termed as canonical or non-canonical (Fig. 2). It is
activated upon mechanical loading e.g., generated
from exercise to initiate osteogenesis and bone
formation (Krishnan et al. 2006), either by direct
stimulation of the bone transcription factor RUNX2
(Gaur et al. 2005) or by crosstalking with PTH or
morphogenetic proteins (BMPs) signalling pathways
(Baron and Kneissel 2013; Gardinier et al. 2016). A
recent investigation showed that circulating PTH,
generated from physical activity, led to downregula-
tion of sclerostin (an anti-anabolic bone protein) in
osteocytes (Gardinier et al. 2016) was accompanied by
significant upregulation of fibroblast growth factor-23
(FGF-23) expression (Gardinier et al. 2016), a growth
factor governing phosphatase homoeostasis and vita-
min D metabolism (Quarles 2012). Collectively, these
findings demostrate the vital role of osteocyte Wnt/b-
catenin signalling in the bone adaptation to exercise.
Exercise could be a means to maintain or enhance a
specific health outcome, such as maximising bone
accretion and/or improving bone strength. Bone adap-
tation to exercise is initiated by muscle contraction
and ground-reaction forces (Sharkey et al. 1995). Bone
traits, such as BMD, strength and architecture, change
and adapt to help the skeleton to cope with the loading
environment while preventing injuries. To illustrate
the bone adaptation response, athletes undertaking
intermittent high impact exercise (Olympic fencers as
just one example) exhibit higher densities of cortical
and trabecular bone than matched controls (Chang
et al. 2009). Similarly, in athlete groups where a highly
active limb can be compared to a less active limb, such
as the racket arm versus non-racket arm of tennis
players (Haapasalo et al. 2000; Ireland et al. 2013) or
in the throwing arm vs non-throwing arm of baseball
players (Warden et al. 2014), there is a greater bone
mass observed in the more active limb. Conversely,
6-months of spaceflight results in a 10% loss in the
BMD of astronauts living under zero gravity condi-
tions, where gravitational mechanical loading and,
therefore, ground-reaction forces are missing (Si-
bonga 2013).
Upon beginning exercise, the skeleton is exposed
to different types of strains (deformation of tissue)
generated from compression, tensile and torsional
forces, and shear stress. Diferent types of strains can
occur at the same time and in the same bone (Judex
et al. 2009). In this study, a compression strain
occurred at 2500 ls on one side of the bone and a
tensile strain of 2000 ls on the other side. It is also
established that running generates tibial strains 2–3
times higher than walking (Burr et al. 1996) and
walking higher than cycling (Milgrom et al. 2000).
The optimal magnitude and frequency to initiate an
osteogenic response in humans is still uncertain as
most studies are undertaken in animals. On the other
side, the optimal exercise to induce osteogenesis and
bone anabolism is likely to change according to age,
sex, the individual (Weaver et al. 2016) and even
skeletal site, suggesting that only a personalised
approach would provide the precision information to
design the optimal osteogenic exercise regimen.
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Bone adaption to exercise across the lifespan
Exercise interventions during childhood
and adolescence
The promotion of physical exercise and healthy eating
habits during bone development maximises the
chances of accruing bone, potentially delaying the
onset of osteoporosis in later life. Such a perspective is
supported by longitudinal studies showing that indi-
viduals who were active during childhood had 8–10%
greater hip bone mineral content (BMC) in adulthood
(age 23–30 years) than their sedentary counterparts
(Baxter-Jones et al. 2008). A more recent longitudinal
trial showed that children engaged in school-based
exercise interventions for 9 months had higher whole-
body (6.2%), femoral neck (8.1%) and total hip (7.7%)
BMC compared with their non-exercising counter-
parts (Meyer et al. 2013). Three years after ceasing the
intervention, the benefits persisted, with a sustained
7–8% increment of BMC in the femoral neck and total
hip of conditioned individuals (Meyer et al. 2013). A
Fig. 2 Simplified diagram depicting canonical and non canon-
ical b-catenin signalling pathways in bone. Exercise enables
bone formation through the active canonical and non-canonical
b-catenin signalling pathways. Activation of the bone transcrip-
tion factor RUNX2 elicits osteogenesis and supresses PPAR-c-
mediated adipogenesis; Activation of WIF1: Wnt Inhibitory
Factor 1: SFRP: Secreted frizzled-related protein; LRP5/6:
Low-density lipoprotein receptor-related protein 5/6; APC:
adenomatous polyposis coli; GSK-3b: glycogen synthase kinase
3 beta; Ub: ubiquitination; P: phosphorylation; b-TrCP: beta-
transducin repeat containing E3 ubiquitin protein ligase; RSPO:
R-spondin 1; WNT3A: Wnt family member 3A; FRAT1:
FRAT1, WNT signalling pathway regulator; DVL: dishevelled
segment polarity protein 1; TCF/LEF: T cell factor/lymphoid
enhancer factor; DKK1: Dickkopf Wnt Signaling Pathway
Inhibitor 1; PTH: Parathyroid hormone; PTH1R: Parathyroid
hormone 1 receptor; SOST: Sclerostin; ROR2: receptor tyrosine
kinase like orphan receptor 2; RYK: receptor-like tyrosine
kinase; WNT5A: Wnt family member 5A; AKT1: AKT serine/
threonine kinase 1; IP3: Inositol trisphosphate; DAAM1:
Disheveled-associated activator of morphogenesis 1; JNK:
c-Jun N-terminal kinases; ROCK: Rho-associated protein
kinase; NFATc1: Nuclear factor of activated T-cells, cytoplas-
mic 1; PPAR-c: Peroxisome proliferator-activated receptor
gamma; RUNX2: Runt-related transcription factor 2. Adapted
from Baron and Kneissel (2013)
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cross-sectional study investigating the long-term ben-
efits of performing upper body exercise (ball throw-
ing) suggested that half of the benefit in bone size and
one-third of the benefit in bone strength was kept
throughout life (Warden et al. 2014). Tveit et al.
(2015) conducted a cross-sectional, cohort study
investigating the long-term, 30 years after retirement,
effects of soccer on BMD, bone structure and fracture
risk. They showed that exercise generated higher
BMD’s, larger bones and a lower fracture risk in
former athletes after retirement (Tveit et al. 2015).
Peak bone mass (PBM) is regarded as a significant
predictor of future osteoporosis and fracture risk
(Specker et al. 2010). Bioinformatics’ and meta-
analyses calculations have estimated that a 10%
increase in PBMwould delay the onset of osteoporosis
by 13 years (Hernandez et al. 2003) and reduce
fracture risk, resulting from osteoporosis, by up to
50% in post-menopausal women (Marshall et al.
1996). A 6.4% decrease in bone mass in childhood has
been associated with a twofold increase fracture risk
during adulthood (Boreham and McKay 2011). This
evidence suggests that exercise interventions, span-
ning childhood and adolescence, are effective, even
after the activity has ceased, although the timing of
initiation may be important. An interesting recent
study has also suggested that the age at which children
first start walking might influence their bone strength
in later life (Ireland et al. 2017). Ireland et al. (2017)
examined the association betweent walking age (ob-
tained at 2 years old) and bone outcomes determined
by DXA and pQCT (between the ages of 60 and
64 years old). Later independent walking age was
associated with lower height-adjusted hip, spine and
distal radius BMC in men, suggesting that the ability
to mechanically load the skeleton early during bone
development might be important in the development
of good bone health.
A systematic review addressing bone mineral
changes in response to weight-bearing exercise (e.g.,
ball games dancing, jumping, and others) proposed
that bone adaptations peak during early puberty
(MacKelvie et al. 2002). More specifically, they
showed that weight-bearing exercise during childhood
had a positive effect on bone strength, while exercise
undertaken during prepubertal and peripubertal ages
caused an increment in bone mineral accrual (MacK-
elvie et al. 2002). These findings were reinforced by a
subsequent systematic review that analysed bone
mineral accrual in children and adolescents (Hind
and Burrows 2007). Despite osteogenesis and bone
anabolism being more pronounced during the peripu-
bertal stage, the ideal modality or training regimen to
optimise bone mass accrual remains to be elucidated.
Exercise interventions during adulthood
Adults might also also benefit from bone-loading
exercise, but systematic reviews and meta-analyses on
the topic (Bolam et al. 2015; Hamilton et al. 2010;
Martyn-St James and Carroll 2010) suggest that this
might occur to a lesser extent than in children and
adolescents (Hind and Burrows, 2007; Nogueira et al.
2014). Nonetheless, Heinonen et al. showed that pre-
menopausal women, aged 35–45 years, who per-
formed a high-impact exercise regimen, consisting
of jump and step training for 18-months, had progres-
sive increases in BMD at the femoral neck (a load
bearing site) when compared with inactive controls
(Heinonen et al. 1996). A meta-analysis, of ran-
domised controlled exercise trials lasting 24 weeks,
also showed improvements in femoral neck and
lumbar spine BMD (Kelley et al. 2013). Bassey
et al. (1998) examined bone accrual after a 12-month
exercise training intervention in both pre- and post-
menopausal women. Training consisted of vertical
jumping, 6 times per week, and resulted in a 2.8%
increase in femoral BMD in pre-menopausal women,
whereas no improvements were shown in post-
menopausal women after 12- or 18-months of training
and hormone replacement therapy (Bassey et al.
1998). The inability of post-menopausal women to
accrue bone mass after high impact training was later
confirmed by a 12-month randomised controlled trial
on the effect of weight-bearing jumping and oral
alendronate, alone or in combination, on bone mass
and structure (Uusi-Rasi et al. 2003). Exercise alone or
in combination with alendronate had no effect on bone
mass at the femoral neck or lumbar spine (Uusi-Rasi
et al. 2003). The ‘‘anabolic resistance’’ to exercise
shown in post-menopausal women likely results, at
least in part, from depleted oestrogen levels (Ji and Yu
2015). Oestrogen is a pleiotropic hormone, with a vital
role in skeletal growth and bone homoeostasis, as well
as in sexual dimorphism and reproduction (Weitz-
mann and Pacifici 2006). All bone cells have oestrogen
receptors and when circulating levels of oestrogen
drop, Wnt/b-catenin and the oestrogen ERb/GSK-3b-
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dependent signalling pathways are attenuated, leading
to reduced osteoblastic proliferation (Yin et al. 2015).
Attenuation of these signalling pathways, with con-
comitant diminished osteoblastic proliferation, is
thought to cause the lack of responsiveness of post-
menopausal women to bone-loading exercises (Yin
et al. 2015).
Although these studies have shown that osteogenic
and bone anabolic effects, resulting from exercise, are
less pronounced or are even negligible when coupled
with oestrogen depletion, post-menopausal women are
strongly advised to undertake exercise. Exercise, of
the right type, might well contribute to BMD preser-
vation, presumably by maintaining cortical and tra-
becular volumetric BMD (Polidoulis et al. 2011), and
by contributing to bone strength by means of cortical
bone thickening (Uusi-Rasi et al. 2003). Among the
exercise modalities tested in this population, walking
provided modest benefits, due to the minor mechanical
load exerted on the skeleton, while resistance and
multi-component exercise programmes, encompass-
ing strength, aerobic, and whole-body vibration exer-
cises, were more effective in mitigating the loss of
bone mass (Gomez-Cabello et al. 2012).
Exercise interventions during older age
Studies investigating exercise on bone health in older
people (50s and above) are scarce. A comparative
study, which enrolled men and women in their early
50s, demonstrated that after 24 weeks of moderate
strength or high intensity training, men that undertook
the high intensity program gained 1.9% BMD in
the spine, while women did not (Maddalozzo and
Snow 2000). Allison et al. (2015) conducted a
12-month randomised controlled trial in male partic-
ipants, aged 65–80 years, who performed unilateral
hopping exercise, whilst the other leg remained as an
inactive control. In this trial, computer tomography
(CT) and DXA measurements demonstrated that
unilateral hopping caused an increase in BMC in both
legs, with the trained leg depicting localised changes
in the proximal femur. Cortical BMC at the trochanter
increased more in the exercising than in the control
leg, which is thought to be important for the structural
integrity of the bone (Allison et al. 2015). A similar
training programme, carried out over 12-months in
men aged 65–80 years, showed increased femoral
neck BMD, BMC and geometry (Allison et al. 2013).
Exercise might contribute to bone health by aug-
menting bone mass and bone strength during younger
age and bymitigating age-relatedbone loss. In practice,
however, this statement might be an oversimplification,
as there are undoubtedly several factors that mediate the
effects of exercise on the bone. Current or previous
habitual levels of exercise, exercise mode, type, inten-
sity and duration will all have a significant influence on
the magnitude of any effects on bone related outcomes.
Recently, Ireland and Rittweger (2017) also suggested
that participationmotivationmight alsoplay a part in the
success or failure of exercise interventions targeted at
the bone (Ireland and Rittweger 2017), which is
certainly an area worthy of consideration.
Although the cellular and molecular mechanisms
underpinning bone outcomes are still under investiga-
tion, the role of the Wnt/b-catenin signalling pathway
both in bone health and as a target of anti-osteoporosis
interventions is becoming increasing clear (Karasik
et al. 2016; Korvala et al. 2012). It was reported that
mechanical loading exerted on mesenchymal stem
cells blocked adipogenic differentiation by rescuing b-
catenin-FOXO mediated transcription to b-catenin-
TCF/LEF mediated transcription (Fig. 3) (Case et al.
2013). This result was corroborated by an in vivo study
involving mice, which demonstrated that exercise
suppressed the accumulation of fat in the bone marrow
(Styner et al. 2014), except that in this case the authors
hypothesised that b-oxidation was the underpinning
mechanism. Another route by which exercise
might mitigate age-related bone loss is through the
prevention of osteocyte apoptosis (Fonseca et al. 2011;
Mann et al. 2006). This was evidenced by research
conducted with ovariectomized mice exposed to
exercise activity and human bone explants exposed
to mechanical tension, with both providing evidence
that mechanical stimulation prevented osteocyte death
(Fonseca et al. 2011; Mann et al. 2006), a fact that
contributes to preservation of bone strength.
Exercise, besides supporting bone health outcomes
such as BMD and bone strength, provides an anti-
ageing effect by virtue of preventing telomere erosion
(Fig. 3) (Loprinzi et al. 2015). A longitudinal study, of
6503 participants aged 20–84 years, showed that
exercise interventions prevented or delayed telomere
shortening, therefore exhibiting an ‘‘age-defying’’ or
rejuvenating action (Loprinzi et al. 2015). This study
suggested that (i) a dose–response relationship exists
between exercise and reduced telomere erosion and
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(ii) this relationship was significant in participants
aged 40–64 years. According to this, undertaking
exercise after the fourth decade of life appears to
improve systemic health on account of the counter-
ageing effect provided. This systemic effect may
mitigate ageing and accordingly age-related bone loss
and age-related osteoporosis. Notably, individuals
with osteoporosis exhibit shorter telomeres than
healthy ones (Valdes et al. 2007), a fact that supports
the notion that preventing or delaying systemic ageing
is beneficial to bone health. Due to the progress of
molecular biology, it is possible that bone health may
also now be appraised by the assessment of telomere
length given that leucocyte telomere shortening cor-
relates with lower BMD at the lumbar spine, femoral
neck and total hip (Nielsen et al. 2015).
Beside the mechanisms illustrated here, we
acknowledge that exercise might contribute to bone
health through other routes as, for example, changes in
hormone levels or by targeting signalling pathways
other than Wnt/b-catenin signalling, such as the BMP
or RANK/RANKL.
Exercise is also linked with epigenetic modifica-
tions, in particular, changes in DNA methylation
patterns and gene expression (Brunet and Berger 2014;
Jung and Pfeifer 2015; Ro¨nn et al. 2013). DNA
methylation is an epigenetic modification typically
leading to long-term gene repression, achieved by the
addition of a methyl group to the five position of a
cytosine ring (Cedar and Bergman 2009). The rela-
tionship between exercise and DNA methylation was
demonstrated in an epidemiological study comprising
two groups; healthy volunteers and type II diabetics
(Ro¨nn et al. 2013). In this study, participants per-
formed spinning and aerobic exercise over a 6-month
period, with an average attendance of 1.8 times per
week. DNA methylation changed in participants from
both groups; more specifically in 7663 genes, one-
Fig. 3 Activation of FOXO transcription signalling upon
oxidative stress (left) in the context of the aged bone; Rescue
of TCF/LEF transcription (a), prevention of osteocyte apoptosis
(b) and prevention of telomere erosion (c) induced by exercise
potentially contribute to bone health
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third of which showed altered mRNA expression
levels (Ro¨nn et al. 2013). In another study, young
sedentary participants of both sexes were exposed to
acute bouts of exercise to ascertain whether acute
exercise could change DNA methylation patterns.
DNA was hypomethylated in skeletal muscle, in a
dose-responsive fashion, with similar findings in
mouse muscles 45 min after ex vivo contraction, both
suggesting a putative role of exercise in epigenetic
modification through DNA methylation (Barre`s et al.
2012). The causal relationship between exercise and
changes in DNAmethylation was further corroborated
by an investigation enrolling young male and female
individuals in a 3-month fully supervised one-legged
exercise training programme. Here, DNAmethylation
patterns changed in 4919 sites across the genome of
the trained leg group (Lindholm et al. 2014). These
epigenetic studies allowed identification of changes in
DNA methylation patterns resulting from exercise on
healthy, type II diabetic and young sedentary popula-
tions. To undertake similar studies in the older
individual might reveal an age reversing epigenetic
signature induced by exercise that might be utilised as
a technique to asses not only bone health but also the
effect of exercise in older individuals with chronic
bone diseases.
Conclusions
Osteoporosis is a bone metabolic disease that prevails
in post-menopausal women. The first line of treatment
relies on anti-osteoporotic drugs, particularly bispho-
sphonates, although this type of therapy can only be
provided for a limited period of time and the benefits
are transient. Exercise has the potential to provide a
means of non-pharmacological intervention, with
long-lasting effects that can delay the onset of
osteoporosis, particularly if performed during the
peripubertal stage, a time during which exercise-
induced osteogenesis and bone anabolism is more
accentuated. There are no current data, however, to
directly compare appropriate exercise with pharma-
cological interventions designed to prevent bone loss
or increase bone mass. These studies are urgently
required to determine the extent to which exercise may
or may not be able to provide a sole (highly unlikely)
or adjunct therapeutic intervention against
osteoporosis.
Exercise might be recommended following the
menopause to mitigate the age- and menopausal-
related loss of bone and to strengthen cortical bone.
During growth and development PBM should be
maximised, with exercise potentially providing a
means to help achieve this. During middle- and
older-age, weight-bearing exercises should be per-
formed to maintain bone mass and increase bone
strength. It remains largely unknown, however, what
the best type of exercise is in terms of mode, type,
intensity and duration to maximise bone responses. It
is likely that any exercise would need to be high-
intensity, high-impact, multidirectional and possibly
unaccustomed in order to optimise osteogenic
responses, but this approach might not be suitable for
all.
Glossary
Acronym Definition
Dual-energy
X-ray
absorptiometry
DXA Standard methods to measure
BMD. Two X-ray beams with
different energy levels are
conveyed to the patient’s
bone. After subtracting the
signal from soft tissue, the
obtained absorption values
allow to estimate bone BMD
Computed
tomography
CT Imagining technique that
allows obtaining detailed
scans of areas inside the body
Bone mineral
density
BMD Refers to the amount of mineral
matter per square centimetre
of bone. BMD is utilised as
predictor of osteoporosis and
fracture risk. Parameter
utilised to estimate bone
strength
Aerial bone
mineral density
aBMD It is a reasonable estimate of
BMC and bone strength, not
an accurate measurement of
true bone mineral density,
which is mass divided by
volume. Parameter utilised to
estimate bone strength
Bone mineral
content
BMC Estimated by DXA, these
measurements reflect BMD at
specific body parts, spine, hip,
wrist, femur or other selected
part of the skeleton. The
values obtained are divided
by the surface area of the bone
being measure to create BMD
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Acronym Definition
Peak bone mass PBM Amount of bone gained by the
time a stable skeletal state has
been attained. At a population
level, peak bone mass reflects
the maximum bone mass
attained across the lifespan. It
is a predictor of osteoporosis
Volumetric peak
bone mass
vPBM Refers the amount of peak bone
mineral content per cubic
centimetre of bone
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